Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial.

Song Z, Wang W, Li P, Zuo X, Zhu Y, Chen Y, Zhang X, Lyu B, Lin R, Du Y, Lan C, Wu H, Chen W, Ye Y, Fan H, Liao A, Chen H, Liu C, Zhang Z, Wang W, Suo Z, Li X, Du Q, Li X, Pan F, Tang J, Xu M, Liu X, Zheng P, Chen H, Du L, Lu J, Feng C, Pan W, Wang H, Zeng Z, Wang J, Lyu S, Liu D, Yang S, Li L, Zhou L

Open source

DOI: 10.1097/cm9.0000000000003780
Published: 2025 Aug 22
Container: Chinese medical journal
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cm9.0000000000003780,
  title = {Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial.},
  author = {Song Z and Wang W and Li P and Zuo X and Zhu Y and Chen Y and Zhang X and Lyu B and Lin R and Du Y and Lan C and Wu H and Chen W and Ye Y and Fan H and Liao A and Chen H and Liu C and Zhang Z and Wang W and Suo Z and Li X and Du Q and Li X and Pan F and Tang J and Xu M and Liu X and Zheng P and Chen H and Du L and Lu J and Feng C and Pan W and Wang H and Zeng Z and Wang J and Lyu S and Liu D and Yang S and Li L and Zhou L},
  year = {2025},
  journal = {Chinese medical journal},
  doi = {10.1097/cm9.0000000000003780},
  url = {https://doi.org/10.1097/cm9.0000000000003780}
}

RIS

TY  - JOUR
TI  - Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial.
AU  - Song Z
AU  - Wang W
AU  - Li P
AU  - Zuo X
AU  - Zhu Y
AU  - Chen Y
AU  - Zhang X
AU  - Lyu B
AU  - Lin R
AU  - Du Y
AU  - Lan C
AU  - Wu H
AU  - Chen W
AU  - Ye Y
AU  - Fan H
AU  - Liao A
AU  - Chen H
AU  - Liu C
AU  - Zhang Z
AU  - Wang W
AU  - Suo Z
AU  - Li X
AU  - Du Q
AU  - Li X
AU  - Pan F
AU  - Tang J
AU  - Xu M
AU  - Liu X
AU  - Zheng P
AU  - Chen H
AU  - Du L
AU  - Lu J
AU  - Feng C
AU  - Pan W
AU  - Wang H
AU  - Zeng Z
AU  - Wang J
AU  - Lyu S
AU  - Liu D
AU  - Yang S
AU  - Li L
AU  - Zhou L
PY  - 2025
JO  - Chinese medical journal
DO  - 10.1097/cm9.0000000000003780
UR  - https://doi.org/10.1097/cm9.0000000000003780
ER  -

APA

Z, S., W, W., P, L., X, Z., Y, Z., Y, C., X, Z., B, L., R, L., Y, D., C, L., H, W., W, C., Y, Y., H, F., A, L., H, C., C, L., Z, Z., W, W., Z, S., X, L., Q, D., X, L., F, P., J, T., M, X., X, L., P, Z., H, C., L, D., J, L., C, F., W, P., H, W., Z, Z., J, W., S, L., D, L., S, Y., L, L., & L, Z. (2025). Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial.. Chinese medical journal. https://doi.org/10.1097/cm9.0000000000003780

Source records

pubmed · retrieved 2026-09-27T13:22:21.214Z